Open Access research which pushes advances in bionanotechnology

Strathprints makes available scholarly Open Access content by researchers in the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) , based within the Faculty of Science.

SIPBS is a major research centre in Scotland focusing on 'new medicines', 'better medicines' and 'better use of medicines'. This includes the exploration of nanoparticles and nanomedicines within the wider research agenda of bionanotechnology, in which the tools of nanotechnology are applied to solve biological problems. At SIPBS multidisciplinary approaches are also pursued to improve bioscience understanding of novel therapeutic targets with the aim of developing therapeutic interventions and the investigation, development and manufacture of drug substances and products.

Explore the Open Access research of SIPBS. Or explore all of Strathclyde's Open Access research...

Strathprints

Open Access @ Strathclyde

Open Access isn't always a piece of cake...

...which is why we are here to help!

Open Access can at first seem complicated. That is why our team is available on Twitter and Tumblr. These can be followed for the latest news and updates, or to post questions.

But it is also why we are developing a new website providing detailed guidance for Strathclyde staff on some of the biggest issues which are likely to appear bemusing or bewildering to colleagues. Our Open Access @ Strathclyde website will provide guidance on:

Important concepts in Open Access, such the difference between Green and Gold Open Access;
Open Access policies a specific research funders, such as HEFCE, RCUK, COAF, ERC, etc.;
PURE and Strathprints;
Copyright and licencing;
Making article processing charge (APC) payments for Gold Open Access articles and how eligible Strathclyde staff can apply for funds;
Research Data Management;
...and much more...

Of course, any general enquiries about Open Access can be directed to our Open Access mailbox.

An image of an Open Access cake being sliced

Image: CC-BY